The Global Cell Viability Assays Market is Predict to reach $2.5 Billion by 2028, at a CAGR of 9.7%

Published Date: 20-Jan-2023

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Cell Viability Assays Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Cell Viability Assays Market size is expected to reach $2.5 billion by 2028, rising at a market growth of 9.7% CAGR during the forecast period.

The Consumables segment acquired maximum revenue share in the Global Cell Viability Assays Market by Product in 2021 thereby, achieving a market value of $1.4 billion by 2028. This is because of the usage of consumables in the numerous stem cell, diagnostic and pharmaceutical, and biopharmaceutical research applications. Also, many key players are offering a wider variety of cell viability assay reagents that are non-toxic and usage ready while ensuring instant high-value results.

The CROs & CMOs segment is showcasing a CAGR of 9.9% during (2022 - 2028). The growth is result of the collaborations between the CROs & CMOs, and pharmaceutical companies to meet various needs. With these joint efforts, there is the possibility of improving process efficiency, reducing market time, and cost-cutting. As a result, the use of cell viability assays for various applications, like drug discovery and development, is expected to increase, thus fueling segment growth.

The Stem Cell Research segment is leading the Global Cell Viability Assays Market by Application in 2021 thereby, achieving a market value of $1 billion by 2028. This is because the stem cell therapy has evolved and become a promising scientific research area. To aid the research, many companies are creating more enhanced novel instruments. These innovations decrease error-prone and manual steps while drastically reducing the turnaround time, which helps analyze and enumerate viable cells.

The North America market dominated the Global Cell Viability Assays Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $879.6 million by 2028. The Europe market is exhibiting a CAGR of 9% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 10.7% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/cell-viability-assays-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.

Global Cell Viability Assays Market Segmentation

By Product

  • Consumables
    • Reagents & Assay Kits
      • Luminometric Assays
      • Dye Exclusion Assays
      • Colorimetric Assays
      • Fluorometric Assays
    • Microplates
  • Instruments
    • Spectrophotometer
    • Microscopy
    • Cell Imaging & Analysis System
    • Flow Cytometry
    • Others

By End User

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes
  • Diagnostic Labs

By Application

  • Stem Cell Research
  • Drug Discovery & Development
  • Diagnostics

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • PerkinElmer Inc.
  • Promega Corporation
  • Biotium
  • Creative Bioarray
  • Abcam Plc

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Cell Viability Assays Market Future Scope & Opportunities 2022-2028

Europe Cell Viability Assays Market Size & Growth Forecast 2022-2028

Asia Pacific Cell Viability Assays Market Size, Share & Industry Outlook to 2028

LAMEA Cell Viability Assays Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.